The Becker Report: Becker Business Media

In this webinar turned podcast,  Venkat Mocherla, Dr. Stephen Klasko, Manav Sevak, and Dr. Andrew Gostine join Scott Becker to explore the realities of building in healthcare, the transformative potential of AI, lessons for entrepreneurs, and strategies for driving meaningful growth.

In this episode, Scott Becker reflects on the challenges of being a middle-aged athlete and explores strategies for bouncing back when things go off track.

In this episode, Scott Becker discusses Peloton’s volatile performance, from its sharp post-COVID decline and brief rebound to its recent downturn.

In this episode, Scott Becker shares four quick insights on Palantir’s recent downturn, including its five-day losing streak, year-to-date performance, and the impact of short-seller Andrew Left’s position against the company.

In this episode, Scott Becker reviews five key business stories including Intel’s surge on SoftBank investment news, Palantir’s rare five-day decline, and more.

This episode features Kimberly Weiner, Founder and CEO of Fluffology, who shares how her passion for animals inspired a new, transparent approach to pet grooming. She discusses the challenges of building a brand from the ground up, lessons learned as an entrepreneur, and her vision for expanding Fluffology’s unique model nationwide.

In this episode, Scott Becker examines GoodRx’s 30% surge after entering the weight loss drug market, the rapid growth of hims and hers, and Novo Nordisk’s move to cut prices on Ozempic as competition in the GLP-1 space intensifies.

In this episode, Scott Becker reflects on two favorite quotes, one on the power of self-transformation and another on how personal well-being strengthens every kind of relationship.

In this episode, Scott Becker reviews a Twitter poll asking who is more unethical, Jim Harbaugh or Pete Rose.

In this episode, Scott Becker highlights nine key stories including market trends, inflation uncertainty, Amazon’s growth challenges, the future of weight loss drugs, and more.